Hood River Capital Management’s Transmedics TMDX Stock Holding History

Hood River Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$69.6M	Buy	699,770 +9,413	+1%	+$1.23M	0.7%	49
2025 Q4	$84M	Buy	690,357 +11,920	+2%	+$1.5M	0.92%	39
2025 Q3	$76.1M	Sell	678,437 -1,410	-0.2%	-$165K	0.9%	38
2025 Q2	$91.1M	Sell	679,847 -115,924	-15%	-$12.7M	1.27%	21
2025 Q1	$53.5M	Buy	+795,771	New	+$54.7M	0.91%	46
2024 Q4	–	Sell	-344,551	Closed	-$54.1M	–	178
2024 Q3	$54.1M	Buy	344,551 +219,377	+175%	+$33.8M	0.87%	44
2024 Q2	$18.9M	Buy	+125,174	New	+$15M	0.39%	84

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hood River Capital Management's TMDX Position: Q1 2026 in Review

Hood River Capital Management increased its Transmedics (TMDX) stake by 1.4% in Q1 2026, buying an estimated $1.23M and bringing the position to 699,770 shares worth $69.6M. The position accounts for 0.7% of the portfolio, ranked #49.

Hood River Capital Management first reported a position in TMDX in Q2 2024 and has held it in 7 quarters since. The position peaked at $91.1M in Q2 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Hood River Capital Management held 699,770 shares of Transmedics worth $69.6M as of Q1 2026.
Hood River Capital Management bought 9,413 Transmedics shares in Q1 2026, an estimated $1.23M.
Transmedics made up 0.7% of Hood River Capital Management's portfolio in Q1 2026, its #49 holding.
Hood River Capital Management first reported a position in Transmedics in Q2 2024 and has held it in 7 quarters since.
Hood River Capital Management's Transmedics position peaked at $91.1M in Q2 2025.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Hood River Capital Management's 13F filing for Q1 2026, filed 15 May 2026.